文献速递免疫规划

与胆固醇基氨基普鲁兰纳米凝胶共价结合的白蛋白抗原在树突状细胞中降解延迟并增强免疫原性

Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity.
PubMed 文献 · Vaccine · 2021-11-29

研究在小鼠中证明,皮下免疫与NH2-CHP纳米凝胶化学结合的牛血清白蛋白可诱导强抗体产生,该效应依赖共价结合而非纳米凝胶形成;结合使抗原在树突状细胞内持续存在,可能通过延迟溶酶体降解增强抗体产生。

要点

  • NH2-CHP纳米凝胶共价结合牛血清白蛋白可增强小鼠皮下免疫的抗体产生。
  • 抗体增强需抗原与CHP共价结合,但不需要纳米凝胶形成。
  • 共价结合使牛血清白蛋白在体内树突状细胞中持续存在。

核心结论

  • 与纳米颗粒共价结合延迟抗原降解可能是开发有效疫苗的良好策略。

研究设计与样本

  • 小鼠皮下免疫实验,比较牛血清白蛋白与NH2-CHP纳米凝胶化学结合后的抗体产生。

主要发现

  • 小鼠皮下免疫化学结合NH2-CHP纳米凝胶的牛血清白蛋白诱导强抗体产生。
  • 抗体产生增强需要牛血清白蛋白与CHP共价结合,但不需要纳米凝胶形成。
  • NH2-CHP纳米凝胶结合使牛血清白蛋白在体内树突状细胞中持续存在。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carriers that augment delivery, immunogenicity or both are crucial in the development of vaccines especially component vaccines as components of pathogens are often poorly immunogenic. Cholesteryl pullulan (CHP) that forms nano-sized hydrogel (nanogel) and encapsulates proteins was shown to be useful in the delivery of vaccines. Here we demonstrate that subcutaneous immunization of mice with bovine serum albumin (BSA) chemically conjugated to NH2-CHP nanogel induces strong antibody production. This augmented antibody production requires covalent conjugation between BSA and CHP, but does not require nanogel formation. Conjugation of NH2-CHP nanogel induces persistence of BSA in dendritic cells (DCs) in vivo. As resistance to lysosomal degradation was previously shown to augment antigen presentation by DCs, conjugation of antigens with CHP nanogel may enhance antibody production to antigens by delaying lysosomal degradation. Therefore, delayed degradation of antigens by covalent conjugation with nanoparticles may be a good strategy for the development of effective vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Long W, Kunitake S, Sawada SI, et al. Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity. Vaccine. 2021. PMID: 34852944. doi:10.1016/j.vaccine.2021.11.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。